+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dobutamine"

Inotropic Agents Global Market Report 2024 - Product Thumbnail Image

Inotropic Agents Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Hypovolemic shock - Pipeline Insight, 2024 - Product Thumbnail Image

Hypovolemic shock - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
From
From
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Dobutamine is a cardiovascular drug used to treat heart failure and other cardiac conditions. It is a synthetic catecholamine that acts as a positive inotropic agent, meaning it increases the force of contraction of the heart muscle. It is administered intravenously and is used to treat low cardiac output states, such as those caused by myocardial infarction, cardiomyopathy, and septic shock. It is also used to treat hypotension and bradycardia. Dobutamine is often used in combination with other drugs, such as diuretics, to treat heart failure. The Dobutamine market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies include Bristol-Myers Squibb, AstraZeneca, and Teva Pharmaceuticals. Show Less Read more